Mid-treatment PET predicts progression in hypofractionated accelerated radiation therapy for lung tumors

被引：0
|
作者：
Chang, Christine N. [1 ]
Fillion, Edith [2 ]
Chapman, Chris [1 ]
Rao, Aarti [1 ]
Wakelee, Heather [2 ]
Ganjoo, Kristen [2 ]
Le, Quynh-Thu [1 ]
Maxim, Peter [1 ]
Quon, Andrew [2 ]
Graves, Edward E. [2 ]
Loo, Billy W. [1 ]
机构：
[1] Stanford Univ Hosp, Stanford, CA 94305 USA
[2] Stanford Canc Ctr, Stanford, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S939 / S939
页数：1
相关论文
共 50 条
  • [21] Early Response Assessment on Mid-treatment Computed Tomography Predicts for Locoregional Recurrence in Oropharyngeal Cancer Patients Treated With Definitive Radiation Therapy
    Kabarriti, Rafi
    Brodin, N. Patrik
    Lundgren, George
    Ohri, Nitin
    Tome, Wolfgang A.
    Kalnicki, Shalom
    Garg, Madhur K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (04): : 1036 - 1045
  • [22] Hypofractionated Radiation Therapy vs Stereotactic Body Radiation Therapy for Ultra-Central Lung Tumors
    Song, R.
    Burrows, C.
    Nsouli, T.
    Alden, R.
    Bogart, J.
    Mix, M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S527 - S528
  • [23] Mid-Treatment Response to 177-Lutetium Dotatate Predicts Overall Outcome in Patients With Advanced Neuroendocrine Tumors
    Halperin, Reut
    Tirosh, Amit
    JCO ONCOLOGY PRACTICE, 2024, 20 (10)
  • [24] In Silico Trial of MR-Guided Mid-Treatment Adaptive Planning for Hypofractionated Stereotactic Radiotherapy in Centrally Located Thoracic Tumors
    Henke, Lauren E.
    Kashani, Rojano
    Przybysz, Daniel
    Hilliard, Jessica
    Curcuru, Austen
    Green, Olga L.
    Bradley, Jeffrey D.
    Robinson, Clifford G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : E3 - E3
  • [25] A Mid-Treatment Increase in Albi Score Is Strongly Associated with Treatment Related Toxicity Following Liver Radiation Therapy
    Jackson, W. C.
    Hartman, H. E.
    Gharzai, L. A.
    Maurino, C.
    Karnak, D.
    Mendiratta-Lala, M.
    Parikh, N. D.
    Mayo, C.
    Ten Haken, R. K.
    Schipper, M.
    Cuneo, K. C.
    Lawrence, T. S.
    Owen, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S206 - S207
  • [26] Mid-Treatment PET During Radiation Therapy in HPV-Positive Oropharyngeal Cancer Patients Demonstrates Variable Response: Implications for Treatment De-escalation
    Riaz, N.
    Pena, A.
    Rosenberg, S.
    Kannarunimit, D.
    Rao, S.
    Lee, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 88 (02): : 500 - 501
  • [27] Stereotactic Body Radiation Therapy (SBRT) and Image Guided Accelerated Hypofractionated Radiation Therapy (IGAHRT) for the Treatment of Oligometastatic Cancers
    Ayala-Peacock, D. N.
    Blackstock, A. W.
    Kearns, W. T.
    Hinson, W. H.
    Munley, M. T.
    Miller, A. A.
    Petty, W. J.
    Urbanic, J. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S567 - S568
  • [28] The impact of mid-treatment MRI on defining boost volumes in the radiation treatment of glioblastoma multiforme
    Manon, R
    Hui, S
    Chinnaiyan, P
    Suh, J
    Chang, E
    Timmerman, R
    Phan, S
    Das, R
    Mehta, M
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2004, 3 (03) : 303 - 307
  • [29] Mid-Treatment [18]F-FDG PET Uptakes Can Predict Symptomatic Radiation Pneumonitis in Non-Small Cell Lung Cancer Patients
    Ajdari, A.
    Shusharina, N.
    Liao, Z.
    Mohan, R.
    Bortfeld, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S224 - S224
  • [30] Adapting Biologically Optimized Dose Escalation Based On Mid-Treatment PET/CT for Non-Small-Cell Lung Cancer
    Zhang, P.
    Kuo, L.
    Yorke, E.
    Hu, Y.
    Lockney, N.
    Mageras, G.
    Deasy, J.
    Rimner, A.
    MEDICAL PHYSICS, 2016, 43 (06) : 3323 - 3323
12345